EssilorLuxottica (ESLOY, Financial) reported sustained growth in the first quarter, driven by robust performances across all regions and business segments. The company is making headway in the wearables and medical technology sectors, showcasing significant progress towards its strategic ambitions.
Recent developments include the unveiling of long-term clinical data on Stellest, highlighting its effectiveness in decelerating myopia progression. Additionally, the launch of Nuance Audio marks the company's entry into an entirely new category in the U.S., Italy, and France, further expanding its market presence.
EssilorLuxottica's brands have shown remarkable momentum. Ray-Ban Meta continues its impressive growth trajectory, while Oakley celebrates half a century as a leader in sport performance eyewear. Moreover, Oliver Peoples has extended its collaboration with tennis legend Roger Federer, enhancing its brand appeal.
The company's progress is underpinned by a workforce of 200,000 employees. Their active participation as shareholders underscores their confidence in the company's direction and values. Despite the challenging global landscape, EssilorLuxottica is poised for continued advancement, with a clear focus on strategic growth and innovation.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Essilorluxottica (ESLOY, Financial) is $121.29 with a high estimate of $121.29 and a low estimate of $121.29. The average target implies an downside of 16.36% from the current price of $145.01. More detailed estimate data can be found on the Essilorluxottica (ESLOY) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Essilorluxottica's (ESLOY, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Essilorluxottica (ESLOY, Financial) in one year is $116.06, suggesting a downside of 19.96% from the current price of $145.01. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Essilorluxottica (ESLOY) Summary page.
